Fasching PA, Link T, Hauke J, Seither F, et al. Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in
patients with HER2-negative breast cancer and homologous recombination deficiency
(GeparOLA study). Ann Oncol 2020 Oct 21. pii: S0923-7534(20)42963.
PMID: 33098995